The prenatal use of KANET scoring in fetal isolated mild ventriculomegaly: A single center study

Abstract

Kurjak Antenatal Neurodevelopmental Test (KANET) was developed for the assessment of fetal neurobehavior and the detection of neurological disorders. We aimed to evaluate the prenatal use of KANET scoring in fetuses with isolated ventriculomegaly in the third trimester of pregnancy. The present study was planned as a prospective and cohort trial. A total of 75 pregnant women; 41 healthy controls and 34 pregnancies with isolated mild ventriculomegaly fetuses were included in the study. All pregnant women were assessed with KANET scoring by 4 dimension ultrasound in the third trimester of pregnancy. The obstetric outcomes of the pregnant women were also recorded. The study and control groups exhibited no significant difference with respect to maternal age, body mass index, delivery week and other obstetric outcomes. The KANET scores of the fetuses (16±2 versus 15±2, p: 0.241) were similar between the study and control groups. Prenatally diagnosed isolated mild ventriculomegaly has not any effect on fetal neurobehavior which was assessed by KANET scoring in the third trimester gestation. The frequent and widespread use of 4 dimension ultrasound in obstetric routine practice would improve the early diagnosis of fetal neurological disorders.